Boothbay Fund Management »

Theriva Biologics shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Theriva Biologics (TOVX) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Theriva Biologics

Tip: Access up to 7 years of quarterly data

All positions including Theriva Biologics held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theriva Biologics by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $14k 36k 0.41
2025-06-30 $15k 36k 0.43
2025-03-31 $39k 36k 1.10

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Gbl Comm Svc Etf Put Option (IXP)
Tesla Motors Call Option (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Palantir Technologies Cl A (PLTR)
Alphabet Cap Stk Cl C Call Option (GOOG)
Amazon Call Option (AMZN)
Select Sector Spdr Tr Indl Put Option (XLI)
Invesco Exch Traded Fd Tr Ii S&p Midcp Low Call Option (XMLV)
Broadcom (AVGO)
Cornerstone Strategic Value (CLM)
Advanced Micro Devices Call Option (AMD)
Apple Call Option (AAPL)

View all positions for Boothbay Fund Management

Top funds holding Theriva Biologics

Ikarian Capital
Two Sigma Investments
Virtu Financial
Jane Street
Boothbay Fund Management
XTX Topco
Geode Capital Management
Two Sigma Advisers
UBS Group
Vanguard Group
Hrt Financial
BlackRock
Advisor Group Holdings
Clear Street
SBI Securities

View all funds holding Theriva Biologics